Ariad Pharmaceuticals, Inc. Community Page | What other sites are saying about Ariad Pharmaceuticals, Inc.

Ariad Pharmaceuticals, Inc.

(NQ: ARIA)

17.81 USD -0.26 (-1.44%)

Official Closing Price / Updated: 4:00 PM EDT, Jun 17, 2013 / Add to My Watchlist

(ARIA) Community Analysis from

READ MORE (ARIA)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

June 17, 2013

(ARIA) Ariad Pharmaceuticals Posts Wider Year Over Year Loss

(Stock Blog Hub, 5/15/13)

Ariad Pharmaceuticals, Inc. (ARIA) reported first quarter loss of 36 cents per share, wider than the year-ago loss of 25 cents per share but narrower than the Zacks...(read more)

(ARIA) Ariad Pharmaceuticals Presents Data on AP26113

(Stock Blog Hub, 4/21/13)

Ariad Pharmaceuticals, Inc. (ARIA) recently presented pre-clinical data on AP26113. The data presented by the company revealed that AP26113 can inhibit clinically relevant...(read more)

SAC Capital Buys More Ariad Pharmaceuticals (ARIA)

(market folly, 4/30/12)

Steve Cohen's hedge fund SAC Capital filed a 13G with the SEC regarding its ownership stake in Ariad Pharmaceuticals (ARIA). SAC now owns 4.9% of the company with 7,876,700 shares. This is a 208%...(read more)

View all posts about ARIAD Pharmaceuticals (ARIA)

ARIAD Pharmaceuticals (ARIA) Company Overview

There is no analysis for ARIA yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates